熱點掃描 | 港股科技股集體高開
uSMART盈立智投10月8日消息，截止發稿，港股三大指數漲跌不一，恆生指數漲0.37%報24792.76點，成交額436.42億；恆生科技指數漲0.88%報6226.24點，成交額129.48億；紅籌指數跌0.62%報3910.98點，成交額17.50億。
板塊方面：
港股科技股集體高開，延續昨日漲勢。網易漲近8%，阿裏巴巴漲4.8%，嗶哩嗶哩漲4.1%，騰訊控股、京東漲近4%，美團漲近3%。
港股互聯網醫療板塊拉昇，阿裏健康漲4.2%，平安好醫生漲3.3%，京東健康漲3%。
港股煤炭股集體下挫，中煤能源跌8.2%，兗州煤業跌7.8%，伊泰煤炭跌6%，易大宗跌4.7%，中國神華跌4.2%。網傳內蒙古要求加快釋放部門煤礦產能。
港股電力股全線走低，中國電力跌10%，華能國際電力跌9%，華潤電力跌6.6%，大唐發電跌6.4%，華電國際電力跌6%。
個股方面：
瑞聲科技跌9.7%，預計第三季度綜合淨利同比減少約51%-61%。
百濟神州漲3.85%，旗下產品百悅澤在澳大利亞獲批用於治療華氏巨球蛋白血癥（WM）。
IMAX中國漲3.54%，十一黃金週（9月30日至10月7日）以1.68億票房刷新史上最佳國慶檔紀錄且同比增30%。
開拓藥業-B(09939.HK)再漲超8%暫現三連陽，克魯胺治療新冠III期臨牀試驗在美國完成首例患者給藥。
碧桂園服務漲超5%，斥2.1億元收購安徽誠和100%股權。
基石藥業-B高開逾7%，公司公佈抗體偶聯藥物CS5001研究數據。
中興通訊急升逾5% 以最大份額中標中國移動(00941.HK)高端路由器集採項目標段四。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
